{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cellulitis-acute/prescribing-information/flucloxacillin/","result":{"pageContext":{"chapter":{"id":"4600d0c1-4cd1-51ee-87a0-b660f0fa2165","slug":"flucloxacillin","fullItemName":"Flucloxacillin","depth":2,"htmlHeader":"<!-- begin field 8b03b4cb-5b1d-4ad7-b0fb-a7e8c39a70a8 --><h2>Flucloxacillin</h2><!-- end field 8b03b4cb-5b1d-4ad7-b0fb-a7e8c39a70a8 -->","summary":"","htmlStringContent":"<!-- begin item a820a61b-c5e6-4ff8-844a-4d7bff190fc0 --><!-- end item a820a61b-c5e6-4ff8-844a-4d7bff190fc0 -->","topic":{"id":"c0841d82-0a64-5b27-81dc-9a825d85f1bf","topicId":"6db61277-29ef-49cc-bad1-d0d78d0afc10","topicName":"Cellulitis - acute","slug":"cellulitis-acute","lastRevised":"Last revised in January 2021","chapters":[{"id":"84376fdb-da2b-561d-bb40-28b5b1a7e975","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bdf35905-533d-5cb1-bd18-9c1575427a25","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"d6c8c4bd-9395-5840-83c7-67ddfeabdf85","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"59d003f6-dd50-5136-b5c2-c2ea4e4b6f01","slug":"changes","fullItemName":"Changes"},{"id":"f79ca51e-9432-56b1-95de-92ed6133be2b","slug":"update","fullItemName":"Update"}]},{"id":"05002b30-8200-5ccf-b9da-7c96acdb65bd","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"fefb70b6-1d32-5e70-afc6-291fa40b3137","slug":"goals","fullItemName":"Goals"},{"id":"cf84220a-f381-5ca1-aa76-ffb99c4959f6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"aa32cbb7-29d6-58b6-bcde-7702767672ec","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7e039433-2afe-5980-93f0-c20c41976610","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d1411fdd-dc83-5f20-9fa4-ad67b69c195a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ce40a600-51e8-5b3a-86c2-d127f03c16eb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ff60c523-3d6f-5766-8508-98e8cdcf08f5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8e8cfe4a-13f2-573c-ab45-7231016746c4","slug":"definition","fullItemName":"Definition"},{"id":"2b7befe3-0fef-5d4e-b00d-bad6742fb93c","slug":"causes","fullItemName":"Causes"},{"id":"96971948-f52b-561c-84f8-8600f3eff2d4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"4749dc8a-3f24-5e65-a0a3-5d7665ef3085","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ad3d41f6-595b-505c-b020-918f0e086d3f","slug":"complications","fullItemName":"Complications"},{"id":"82ccb916-06d4-5b29-91e4-90005f3db942","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"7305e6df-9b2c-5584-9412-54564432e382","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8625eea6-53ec-5348-befa-a609ea64590f","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"273b1216-536e-59b4-8c39-547a97824ffa","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"68b86e3a-ee13-5ccd-9df0-a5c70c553251","fullItemName":"Management","slug":"management","subChapters":[{"id":"195394ca-067a-5cf3-bc4d-52a189d2cba6","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"4426193a-52c1-59b9-9222-77fb7169a3d1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"78de19b8-8e80-551f-8112-456ce2e25bb0","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"73060223-dd90-59da-bae3-c706b5d24298","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"83f47301-e112-5f78-a79a-5c03a9de9537","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"b7240858-fbcc-5f20-8dcd-19f0b7221ac4","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"07828388-33ed-5e04-90b7-28a76fa26c6e","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"4600d0c1-4cd1-51ee-87a0-b660f0fa2165","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"0c0b7a3f-11e4-5b00-bd21-b66e49f9ad77","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"29987f8b-20b6-5c1f-8d23-183b415a04fb","slug":"analgesia","fullItemName":"Analgesia"}]},{"id":"4b09dc1a-8268-50d6-a164-227a73b3556e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d49b86e1-77b2-58e6-82c0-ea0aa7ee74ed","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fe910063-69df-5218-bb78-36f5863db2a1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"129f5233-2934-55ad-a561-4eb37861dc10","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"74d5b6b4-ef9d-5fc4-b41b-656b81a7ded8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"44402335-ffeb-5e14-9e77-bb8278ef43d6","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"04d7d640-f586-53d9-ac59-804c10dd593d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c50af1ff-f157-5023-92b4-aa07b1c28d76","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4426193a-52c1-59b9-9222-77fb7169a3d1","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"0108d4cf-da57-5863-8ea0-5dcd8e57e93d","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field bbbd9b5c-b9ad-4e57-ada3-e5e898c0e0f1 --><h3>What are the contraindications and cautions for flucloxacillin?</h3><!-- end field bbbd9b5c-b9ad-4e57-ada3-e5e898c0e0f1 -->","summary":"","htmlStringContent":"<!-- begin item 7bda17c3-53f9-434e-84be-d89ec8fe4853 --><!-- begin field 05860cb7-f2af-4121-9009-393e97e78cef --><ul><li><strong>Do not prescribe </strong><strong>flucloxacillin</strong> to people with:<ul><li>A <em>true </em>penicillin hypersensitivity. Gastrointestinal adverse effects alone (such as nausea, vomiting, or diarrhoea) do <em>not </em>constitute an allergy to penicillin. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a> for more information.</li><li>A hypersensitivity to cephalosporins — there is some evidence of partial cross-allergenicity. </li><li>A history of penicillin-associated jaundice or hepatic dysfunction.</li></ul></li><li><strong>Prescribe flucloxacillin with caution </strong>in people with:<ul><li>Hepatic impairment (especially if they are 50 years of age or older, or have a serious underlying disease).</li><li>Severe renal impairment — reduce the dose of flucloxacillin, or the dosing interval, if the estimated glomerular filtration rate (eGFR) is less than 10 mL/minute/1.73 m<sup>2</sup>, due to the risk of neurotoxicity.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field 05860cb7-f2af-4121-9009-393e97e78cef --><!-- end item 7bda17c3-53f9-434e-84be-d89ec8fe4853 -->","subChapters":[]},{"id":"68ad1e4c-a0a8-53bc-8367-c8d4e00694c3","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 71c4cabe-e625-4479-9340-51a3cf58b65b --><h3>What are the possible adverse effects of flucloxacillin?</h3><!-- end field 71c4cabe-e625-4479-9340-51a3cf58b65b -->","summary":"","htmlStringContent":"<!-- begin item 0684288a-86c7-4a54-9053-9496f4153994 --><!-- begin field b428f010-f60c-456d-a1bf-613958feced3 --><ul><li><strong>The most common adverse effects of flucloxacillin </strong>include nausea, vomiting, skin rash, thrombocytopenia, and diarrhoea.<ul><li>Consider pseudomembranous colitis if a person develops severe diarrhoea during or after treatment with flucloxacillin. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li><li><strong>Anaphylaxis (delayed or immediate) </strong>is a serious but rare adverse effect of flucloxacillin. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li><li><strong>Hepatitis and cholestatic jaundice </strong>may occur very rarely after treatment with flucloxacillin. These reactions are related neither to the dose nor to the route of administration of flucloxacillin, and the onset may be delayed for several weeks (up to 2 months) after treatment has stopped. Risk factors include treatment for more than 2 weeks and increasing age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">CSM, 1992</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">CSM, 2004</a>].</li><li><strong>Other adverse effects of penicillins, including flucloxacillin, include:</strong><ul><li>Uncommon — leucopenia.</li><li>Rare or very rare — agranulocytosis, angioedema, arthralgia, eosinophilia, fever, haemolytic anaemia, myalgia, nephritis tubulointerstitial, neutropenia, seizure, and severe cutaneous adverse reactions (SCARs).</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field b428f010-f60c-456d-a1bf-613958feced3 --><!-- end item 0684288a-86c7-4a54-9053-9496f4153994 -->","subChapters":[]},{"id":"bae18c9a-0c1f-5e64-9169-2364f1f2570b","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 6964b0fc-903a-48f5-96e6-0ff8ef19ccb3 --><h3>What are the possible drug interactions of flucloxacillin?</h3><!-- end field 6964b0fc-903a-48f5-96e6-0ff8ef19ccb3 -->","summary":"","htmlStringContent":"<!-- begin item 0b2b26b9-e372-4c34-a5be-1258c7d16f51 --><!-- begin field 3be098b8-470a-40cd-98db-2a26aa411f92 --><ul><li><strong>Possible drug interactions of flucloxacillin include:</strong><ul><li><strong>Anticoagulants (for example warfarin)</strong> — flucloxacillin potentially alters the anticoagulant effect of warfarin.<ul><li>Monitor the prothrombin time or international normalized ratio (INR) more closely with the addition or withdrawal of a penicillin. Adjustment of the anticoagulant dose may be necessary.</li></ul></li><li><strong>Methotrexate</strong> — flucloxacillin is predicted to increase the risk of toxicity when given with methotrexate, and both flucloxacillin and methotrexate can increase the risk of hepatotoxicity.<ul><li>If concurrent treatment is indicated, monitor methotrexate levels more closely. One recommendation is to carry out twice weekly platelet and white cell counts for 2 weeks initially, with the measurement of methotrexate levels if toxicity is suspected.</li></ul></li><li><strong>Food</strong> — the absorption of flucloxacillin may be reduced by food.  <ul><li>Advise that flucloxacillin should be taken one hour before food or on an empty stomach.</li></ul></li></ul></li><li><strong>Oral hormonal contraception</strong> — additional contraceptive precautions are <em>not </em>required during or after courses of penicillins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">FSRH, 2017</a>].<ul><li>However, advise women on the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the section on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> <hyperlink-marker innertext=\"Contraception - combined hormonal methods\" refid=\"-494585\"></hyperlink-marker>and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">ABPI, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field 3be098b8-470a-40cd-98db-2a26aa411f92 --><!-- end item 0b2b26b9-e372-4c34-a5be-1258c7d16f51 -->","subChapters":[]},{"id":"6ff54b3b-7c54-523e-b367-387f179a3bd8","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field 544689c1-5b3e-4623-af0b-441926c18676 --><h3>Can flucloxacillin be used during pregnancy and breastfeeding?</h3><!-- end field 544689c1-5b3e-4623-af0b-441926c18676 -->","summary":"","htmlStringContent":"<!-- begin item 70cf4735-ab23-4502-a139-3fe3584a481d --><!-- begin field 8253bd0b-b997-4ae4-a0f4-5d2a5c078425 --><ul><li><strong>Pregnancy</strong><ul><li>Penicillins are not known to be harmful in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>]. </li><li>The vast majority of the large amount of available data shows no increased risk of congenital malformation, spontaneous abortion, intrauterine death, low birth weight, preterm delivery, or neonatal complications following maternal exposure to therapeutic doses of penicillins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">UKTIS, 2017a</a>].</li></ul></li><li><strong>Breastfeeding</strong><ul><li>Trace amounts of penicillins are found in breastmilk, but it is appropriate to use in women who are breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Joint Formulary Committee, 2019</a>].</li><li>Penicillins (and cephalosporins) are the antibiotics of choice in breastfeeding women [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cellulitis-acute/references/\">Kearney, 2016</a>].</li></ul></li></ul><!-- end field 8253bd0b-b997-4ae4-a0f4-5d2a5c078425 --><!-- end item 70cf4735-ab23-4502-a139-3fe3584a481d -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}